From NDTV
Center-Right Owned by Adani Group (AMG Media)Emcure Pharmaceuticals Q2 Results: Profit Jumps 34%, Revenue Up 24%
What's behind this
Mold‑Tek Packaging Limited reported its Q2 results for the fiscal year 2027, covering the quarter and half‑year ended September 30 2026. The company said profit rose 36% to Rs 21 crore and revenue increased 31%, with growth attributed to its pharma and FMCG segments. The announcement was made in New Delhi on November 3.
AI-generated overview from 2 outlets. It summarises their reporting and adds no reporting of its own.
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
center · 4 outlets
Auto components manufacturer SEDEMAC Mechatronics reported a 30% jump in net profit to ₹39.2 Cr in the second quarter (Q2)…
— Inc42
-
right · 2 outlets
The pharma major's revenue from operations during the September quarter grew 13.6% to Rs 726.86 crore from Rs 642.34 crore, year-on-year (YoY).
— NDTV
RSS excerpt
Emcure Pharmaceuticals' international business grew 34.5% year-on-year in the September quarter, led by strong performances across Europe, Canada, and rest of the world markets.
